Cytonics, founded in 2006, is a private research and development company focused on developing molecular diagnostics and therapeutics for chronic musculoskeletal diseases such as osteoarthritis. The company’s flagship product was a diagnostic test which helps identify the source of joint pain and assists physicians in determining the most appropriate course of treatment.
